LB Pharma prepares IPO to fund Phase 3 test

LB Pharmaceuticals' planned IPO will fund late-stage clinical development of LB-102, a once-daily pill designed to improve on the old Sanofi schizophrenia drug Solian. The IPO filing follow a corporate restructuring in May that cut the jobs of LB's chief financial and scientific officers to streamline operations and extend its cash runway.

Editor's Pick

Top Story With a New Take on an Old Schizophrenia Drug, LB Pharma Prepares IPO to Fund Phase 3 Test LB Pharmaceuticals' planned IPO will fund late-stage clinical development of LB-102, a once-daily pill designed to improve on the old Sanofi schizophrenia drug Solian. The IPO filing follow a corporate restructuring in May that cut the jobs of LB's chief financial and scientific officers to streamline operations and extend its cash runway. Sponsored Discover how Mayo Clinic Platform_Solutions Studio can accelerate the commercialization of your digital health solution. Presented by Mayo Clinic Platform_Solutions Studio Whether you're ready to build, validate, or deploy your AI solution into clinical workflows, Solutions Studio offers comprehensive technical and business support tailored to your needs.  Learn more AI in Healthcare: Beyond the Buzz How do we measure AI's true impact in healthcare? What does it take for an AI-driven company to stand out, and how can we build trust while adopting new tech responsibly? Join us at INVEST Digital Health to hear from industry leaders, spark meaningful conversations, and make connections that open doors to collaboration. Register Today

Featured News

The Role of RWD in Revolutionizing Clinical Trial Design [Sponsored] Using RWD to understand SDOH factors faced by patients with non-small cell lung cancer paves the way for improving health equity and more effective treatments for more people. Duke Spinout Launches Platform to Unite Care and Clinical Research Pluto Health launched an AI-driven digital hub that unifies fragmented health data, provides personalized care navigation and integrates clinical research opportunities to help close primary care access gaps. The platform aims to improve care coordination and make research participation more accessible, especially for patients without insurance or a regular primary care provider. Regeneron's RNA Med for Muscle Disease Meets Trial Goals; FDA Filing Planned for Next Year Cemdisiran, a small interfering RNA drug that Regeneron Pharmaceuticals licensed from Alnylam Pharmaceuticals, met the goals of its pivotal test in generalized myasthenia gravis. The rare neuromuscular disease has several new therapies, but analysts see cemdisiran as having advantages over one particular class of drugs. Dreem Health Launches 3 Partnerships to Address Sleep Disorders Dreem Health introduced partnerships with Moona Health, DrLullaby and Daybreak. The partnerships aim to improve care for sleep conditions like insomnia and sleep apnea. Healthcare Price Transparency is Not Enough Health care in the United States is confusing for patients and consumers. Price transparency is a step in the right direction — transformative change can happen by combining cost, quality, appropriateness and efficiency measures. Evaluating the Complexities of the Digital Operating Room As operating environments become more complex, every element and system must be reliable, safe, and compliant with the web of regulations. Testing is the antidote to address these issues, however, this presents a significant testing burden. Here are some key challenges.

Video   Should For-Profit Companies Be Administering Medicare Advantage Plans? The House Ways and Means Committee's joint oversight and health subcommittee hearing on Medicare Advantage focused on fraud, waste and abuse.  The hearing had seven witnesses, and two of them were the CEOs of Medicare Advantage plans Alignment Health and Scan Health. Notably absent were several large payers, like UnitedHealthcare and Humana, despite past investigations and fines.  This begs the question: should for-profit health plans even be in the business of selling Medicaid Advantage plans?

Sponsored The Definitive Guide to Medical Billing Outsourcing: 5 Top Companies Presented by Global Healthcare Resource In today's healthcare landscape, your choice of medical billing partner directly impacts your bottom line. What are the best medical billing outsourcing companies, and which one is right for you? Learn More.

Resources

MedCity Pivot Podcast: Clinical Documentation Improvement With Smarter Technologies Smarter Technologies CEO Jeremy Delinsky explains how the company's AI infrastructure can help support health system's clinical documentation improvement efforts, ultimately strengthening RCM. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe